Drug Shortage Report for ATACAND PLUS

Last updated on 2020-04-02 History
Report ID 107585
Drug Identification Number 02332957
Brand name ATACAND PLUS
Common or Proper name candesartan cilexetil and hydrochlorothiazide
Company Name ASTRAZENECA CANADA INC
Market Status MARKETED
Active Ingredient(s) HYDROCHLOROTHIAZIDE CANDESARTAN CILEXETIL
Strength(s) 25MG 32MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30 tablets
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Demand increase for the drug.
Anticipated start date 2020-03-24
Actual start date 2020-03-24
Estimated end date 2020-04-17
Actual end date 2020-04-01
Shortage status Resolved
Updated date 2020-04-02
Company comments
Health Canada comments
Company contact information Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2020-04-02 English Compare
v8 2020-04-01 French Compare
v7 2020-04-01 English Compare
v6 2020-03-25 English Compare
v5 2020-03-24 French Compare
v4 2020-03-24 English Compare
v3 2020-03-03 French Compare
v2 2020-03-03 English Compare
v1 2020-03-03 English Compare